Characterizing Adverse Events of Biologic Treatment of T2 Disease: A Disproportionality Analysis of the FDA Adverse Event Reporting System. - Stack TJ; Kim S; Lamb MM; Mohammad I; Zeatoun A; Lopez E; Klatt-Cromwell C; Thorp BD; Ebert CS Jr; Senior BA; Kimple AJ; Alicea D (ORL; journal for oto-rhino-laryngology and its related specialties, 2023)